Stock listing

Coherus Oncology, Inc.

Selected listing: 8C5 · BX · CHF · CH

Coherus Oncology, Inc. (BX Swiss: 8C5), Health Technology. Latest release Sep 23, 2026: Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar…

8C5:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: 8C5
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BX Swiss
Currency: CHF

Latest news from Coherus Oncology, Inc.

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

September 23, 2026

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

August 17, 2026

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update

August 5, 2026

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)

June 23, 2026

All Coherus Oncology, Inc. news →

Events

Replays

Coherus Oncology, Inc. (CHRS) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 05:00 PM ET
Watch
Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call
Mon, May 11, 2026 · 05:00 PM ET
Watch
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call
Mon, Mar 09, 2026 · 04:30 PM ET
Watch

Research Coherus Oncology, Inc.

Coherus Oncology, Inc. company profile

View the public company page for Coherus Oncology, Inc. on 6ix.

Coherus Oncology, Inc. news

Read company news and market updates connected to Coherus Oncology, Inc..

Coherus Oncology, Inc. investor events

Find investor webinars, events, and replay context for Coherus Oncology, Inc..